Education
About Us
Working with TipRanks
Follow Us
Doximity, Inc. (DOCS)
:DOCS
DOCS Stock Chart & Stats
$50.97
-$0.33(-0.59%)
At close: 4:00 PM EST
$50.97
-$0.33(-0.59%)
Day’s Range― - ―
52-Week Range$46.04 - $85.21
Previous CloseN/A
Volume296.07K
Average Volume (3M)2.00M
Market Cap
$9.60B
Enterprise Value$13.82B
Total Cash (Recent Filing)$878.37M
Total Debt (Recent Filing)$11.27M
Price to Earnings (P/E)40.7
Beta1.42
Next Earnings
Feb 05, 2026EPS Estimate
0.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.45
Shares Outstanding137,373,860
10 Day Avg. Volume2,757,371
30 Day Avg. Volume1,996,697
Financial Highlights & Ratios
PEG Ratio0.92
Price to Book (P/B)10.01
Price to Sales (P/S)19.01
P/FCF Ratio40.65
Enterprise Value/Market Cap1.44
Enterprise Value/Revenue22.24
Enterprise Value/Gross Profit24.65
Enterprise Value/Ebitda49.50
Forecast
1Y Price Target
$67.69Price Target Upside32.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)1.58
Revenue Forecast (FY)$644.93M
Bulls Say, Bears Say
Bulls Say
Financial PerformanceDoximity reported incredibly strong FY2Q results with revenue and EBITDA well ahead of expectations.
Growth OpportunitiesMultiple, Sizable Growth Opportunities Ahead. DOCS is currently just 52% and 11% penetrated into U.S. Pharma mega and mid-tier brands, respectively, leaving a long runway for its land-and-expand strategy.
Stock UpgradeUpgrading Doximity from Outperform to Strong Buy following a significant dislocation in shares post F2Q results, with the current risk/reward at 25x FCF looking too compelling to ignore.
Bears Say
Budget DelaysPharma is taking longer to make budget decisions for calendar 2026, resulting in Doximity’s weaker than expected guidance for the next two quarters.
Policy UncertaintyCustomers are also seeing some uncertainty related to policy changes that could influence annual budgets.
Valuation ConcernsWith shares trading ~25x FY27 EBITDA, much of this appears to be priced in.
Doximity News
DOCS FAQ
What was Doximity, Inc.’s price range in the past 12 months?
Doximity, Inc. lowest stock price was $46.04 and its highest was $85.21 in the past 12 months.
What is Doximity, Inc.’s market cap?
Doximity, Inc.’s market cap is $9.60B.
When is Doximity, Inc.’s upcoming earnings report date?
Doximity, Inc.’s upcoming earnings report date is Feb 05, 2026 which is in 69 days.
How were Doximity, Inc.’s earnings last quarter?
Doximity, Inc. released its earnings results on Nov 06, 2025. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.379 by $0.071.
Is Doximity, Inc. overvalued?
According to Wall Street analysts Doximity, Inc.’s price is currently Undervalued.
Does Doximity, Inc. pay dividends?
Doximity, Inc. does not currently pay dividends.
What is Doximity, Inc.’s EPS estimate?
Doximity, Inc.’s EPS estimate is 0.45.
How many shares outstanding does Doximity, Inc. have?
Doximity, Inc. has 137,373,860 shares outstanding.
What happened to Doximity, Inc.’s price movement after its last earnings report?
Doximity, Inc. reported an EPS of $0.45 in its last earnings report, beating expectations of $0.379. Following the earnings report the stock price went down -13.247%.
Which hedge fund is a major shareholder of Doximity, Inc.?
Currently, no hedge funds are holding shares in DOCS
Doximity Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$67.69 (32.80% Upside)
$67.69 (32.80% Upside)
Blogger Sentiment
Bullish
DOCS Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 72.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.80%
12-Months-Change
Fundamentals
Return on Equity
24.61%
Trailing 12-Months
Asset Growth
12.39%
Trailing 12-Months
Company Description
Doximity, Inc.
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
DOCS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Doximity's earnings call highlighted strong financial performance and growth, particularly in revenue and AI adoption. Despite some uncertainties regarding future budgets and increased investment costs, the company's successful integration of Pathway and continued client engagement and expansion indicate a robust position in the market.View all DOCS earnings summariesDOCS Revenue Breakdown
93.00% Subscription
7.00% Other
DOCS Stock 12 Month Forecast
Average Price Target
$67.69
▲(32.80% Upside)
Technical Analysis
Omnicell
―
Evolent Health
―
Teladoc
―
Definitive Healthcare Corp
―
Tempus AI, Inc. Class A
―
Ownership Overview
2.44% Insiders
32.12% Mutual Funds
11.04% Other Institutional Investors
34.48% Public Companies and Individual Investors